Oeuvray C, Bouharoun-Tayoun H, Grass-Masse H, Lepers J P, Ralamboranto L, Tartar A, Druilhe P
Laboratoire de Parasitologie Médicale, Institut Pasteur, Paris, France.
Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:77-80. doi: 10.1590/s0074-02761994000600018.
We report the identification of a 48kDa antigen targeted by antibodies which inhibit Plasmodium falciparum in vitro growth by cooperation with blood monocytes in an ADCI assay correlated to the naturally acquired protection. This protein is located on the surface of the merozoite stage of P. falciparum, and is detectable in all isolates tested. Epidemiological studies demonstrated that peptides derived from the amino acid sequence of MSP-3 contain potent B and T-cell epitopes recognized by a majority of individuals living in endemic areas. Moreover human antibodies either purified on the recombinant protein, or on the synthetic peptide MSP-3b, as well as antibodies raised in mice, were all found to promote parasite killing mediated by monocytes.
我们报告了一种48kDa抗原的鉴定,该抗原是抗体的靶向目标,这些抗体在与自然获得性保护相关的抗体依赖性细胞介导的抑制试验(ADCI)中,通过与血液单核细胞合作来抑制恶性疟原虫的体外生长。这种蛋白质位于恶性疟原虫裂殖子阶段的表面,并且在所有测试的分离株中均可检测到。流行病学研究表明,源自MSP-3氨基酸序列的肽含有大多数流行地区人群所识别的强效B细胞和T细胞表位。此外,无论是在重组蛋白上纯化的人抗体,还是在合成肽MSP-3b上纯化的人抗体,以及在小鼠中产生的抗体,均被发现可促进单核细胞介导的寄生虫杀伤作用。